Stay updated on Orally Administered AG-120 in Hematologic Malignancies Clinical Trial
Sign up to get notified when there's something new on the Orally Administered AG-120 in Hematologic Malignancies Clinical Trial page.

Latest updates to the Orally Administered AG-120 in Hematologic Malignancies Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedAddition of Revision: v3.3.3 to the page history; removal of HHS Vulnerability Disclosure and Revision: v3.3.2 from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check44 days agoChange DetectedRevision: v3.3.2 replaces Revision: v3.2.0 on the page.SummaryDifference0.1%

- Check52 days agoChange DetectedThe funding/operating status notice banner was removed from the page, which previously warned that information may not be up to date due to funding and government operations.SummaryDifference0.4%

- Check73 days agoChange DetectedThe new screenshot preserves the same version history data as the old one, and changes appear limited to UI styling and formatting rather than content — To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check94 days agoChange DetectedUpdate includes a funding/status notice and a version bump to v3.2.0, replacing the previous v3.1.0.SummaryDifference9%

- Check102 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.2%

Stay in the know with updates to Orally Administered AG-120 in Hematologic Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Orally Administered AG-120 in Hematologic Malignancies Clinical Trial page.